RUNX3 regulates the susceptibility against EGFR-targeted non-small cell lung cancer therapy using (47)Sc-conjugated cetuximab

por Kim, Da-Mi, Lee, So-Young, Lim, Jae-Cheong, Cho, Eun-Ha, Park, Ul-Jae
Publicado 2023

Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer

por Dho, So Hee, Kim, Soo Yong, Chung, Chaeuk, Cho, Eun Ha, Lee, So-Young, Kim, Ji Young, Kim, Lark Kyun, Min, Sung-Won, Lee, Jichul, Jung, Sung Hee, Lim, Jae Cheong
Publicado 2018